Clinical trial
Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic…
NCT00107822 · ZARS Pharma Inc., Industry · Completed
Key facts
| NCT number | NCT00107822 |
|---|---|
| Title | Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children |
| Official title | An Open-Label Safety Study to Evaluate the Use of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Pediatric Patients Undergoing a Minor or Major Dermal Procedure |
| Lead sponsor | ZARS Pharma Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%) |
| Enrollment | 80 |
| Start date | Apr 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Apr 11, 2005 |
| Last update posted | Oct 6, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: